Aortic Mural Thrombus Embolization: An Unusual Presentation of Essential Thrombocytosis

https://doi.org/10.1007/s10016-001-0077-9Get rights and content

Hypercoagulable conditions are increasingly recognized as a causative factor in patients with thromboembolic phenomenon. Essential thrombocytosis (ET) is one such condition. This particular myeloproliferative disorder is most commonly associated with thrombotic complications of the microvasculature and bleeding complications involving mucosal surfaces (e.g., gastrointestinal tract bleeding). This case identifies an uncommon manifestation of ET—aortic mural thrombus leading to visceral embolism. Vascular surgeons should be aware of the diagnosis, treatment, and complications of ET, as patients with this condition may first present with an arterial occlusion.

References (32)

  • JB Towne et al.

    Antithrombin deficiency—a cause of unexplained thrombosis in vascular surgery

    Surgery

    (1981)
  • D Green et al.

    Protein C deficiency in splanchnic venous thrombosis

    Am J Med

    (1987)
  • JB Towne et al.

    White clot syndrome: peripheral vascular complications of heparin therapy

    Arch Surg

    (1979)
  • PJ Svensson et al.

    Resistance to activated protein C as a basis for venous thrombosis

    N Engl J Med

    (1994)
  • LM Taylor et al.

    Antiphospholipid antibodies in vascular surgery patients: a cross-sectional study

    Ann Surg

    (1994)
  • S Murphy et al.

    Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group

    Semin Hematol

    (1986)
  • Cited by (10)

    • Aortic Thrombus due to Essential Thrombocytosis: Strategies for Medical and Surgical Management

      2008, Annals of Vascular Surgery
      Citation Excerpt :

      After reducing platelets with hydroxyurea and aspirin, an interval CT scan revealed complete resolution of her intra-aortic thrombus and reduction in the size of the splenic and renal infarctions. In another study, Lorelli and Shepard15 successfully medically managed an 83-year-old female with a nonoccluding thrombus of the supraceliac aorta, partial thrombosis of the portal vein, and near total splenic infarction from ET. This patient was successfully treated with anagrelide and warfarin.

    • Essential thrombocytosis-associated thromboembolism in the abdominal aorta

      2016, Korean Journal of Thoracic and Cardiovascular Surgery
    • Thrombolysis to treat thrombi of the aortic arch

      2011, Clinical and Applied Thrombosis/Hemostasis
    View all citing articles on Scopus
    View full text